Cargando…
Ventricular tachycardia triggered by the first dose of an adenoviral vector‐based COVID‐19 vaccine in an adult patient with congenital heart disease
A unique adverse event of adenoviral COVID‐19 vaccine in an adult patient with congenital heart disease is reported.
Autores principales: | Bassareo, Pier Paolo, Mihali, Klevis, Walsh, Kevin Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468566/ https://www.ncbi.nlm.nih.gov/pubmed/36172331 http://dx.doi.org/10.1002/ccr3.6064 |
Ejemplares similares
-
Ventricular tachycardia in repaired congenital heart disease
por: Zeppenfeld, Katja
Publicado: (2016) -
Strategies to Aid Successful Transition of Adolescents with Congenital Heart Disease: A Systematic Review
por: Bassareo, Pier Paolo, et al.
Publicado: (2023) -
Supraventricular tachycardia triggering polymorphic ventricular tachycardia
por: Oomen, Ad W.G.J., et al.
Publicado: (2019) -
Metabolomics: A New Tool in Our Understanding of Congenital Heart Disease
por: Bassareo, Pier Paolo, et al.
Publicado: (2022) -
Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)